BIOGEN INC. is 15.0x more valuable than Vericel Corp by market capitalization ($28.73 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCEL | BIIB |
|---|---|---|
| Market cap | $1.91 B | $28.73 B |
| US-listed rank | #2131 | #480 |
| Revenue (latest FY) | $276.26M | $9.89B |
| Net income (latest FY) | $16.52M | $1.29B |
| Net margin | 6.0% | 13.1% |
| P/E (trailing FY) | 115.6 | 22.2 |
| SEC filings | 1,674 | 2,690 |
BIOGEN INC. is 15.0x more valuable than Vericel Corp by market capitalization ($28.73 B vs $1.91 B).
In their latest fiscal years, Vericel Corp reported $276.26M in revenue while BIOGEN INC. reported $9.89B.
Full pages: Vericel Corp and BIOGEN INC., or browse the full rankings.